Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer
Shannon L. Stott(Shriners Hospitals for Children - Erie), Shyamala Maheswaran(Massachusetts General Hospital), Sunitha Nagrath(University of Michigan), David T. Miyamoto(Broad Institute), Douglas M. Dahl(Harvard University), Daniel A. Haber(Howard Hughes Medical Institute), Min Yu(Howard Hughes Medical Institute), Richard J. Lee(La Roche College), Zev M. Nakamura(University of North Carolina at Chapel Hill), Maria E. Kempner(Massachusetts General Hospital), Chin‐Lee Wu(Massachusetts General Hospital), Dina Tsukrov(Harvard University), Simeon Springer(Howard Hughes Medical Institute), A. John Iafrate(Massachusetts General Hospital), Lecia V. Sequist(Harvard University), Mehmet Toner(Center for Cancer Research), Alessandra L. Moore(Harvard University), Elizabeth K. Inserra(Harvard University), Matthew R. Smith(Harvard University), Matthew Ulman(Harvard University), Lindsey Ulkus(Harvard University), Ronald G. Tompkins(Nashville Oncology Associates)
Cited by 537
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With <i>EGFR</i> Mutations
|Journal of Clinical Oncology|2013|3.2k
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k